CDK2-IN-41
CDK2-IN-41 (Compound 7a) is a CDK2 inhibitor that exerts anticancer activity by binding to CDK2, thereby inhibiting the cell cycle, inducing cytotoxicity, promoting ROS production, and triggering Apoptosis. CDK2-IN-41 exhibits an IC50 of 10 µM against acute myeloid leukemia (AML) HL-60 cells. It holds potential for research in AML-related cancer therapy.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C19H21N3S
- Peso molecular:323.46
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
CDK2 |
Chemical Information
-
Peso molecular 323.46
-
Fòrmula C19H21N3S
-
SMILES
N#CC1=C2C(CNCC2)=C(C=C1N3CCCCC3)C4=CC=CS4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CDK2-IN-41 Related Classifications
HY-172153 Related Classifications
Powered by Bioz